Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

NIPT 15.76 -0.36 (-2.26%)
price chart
Premaitha Health PLC's (NIPT) "Buy" Rating Reiterated at Panmure Gordon
Premaitha Health PLC logo Panmure Gordon restated their buy rating on shares of Premaitha Health PLC (LON:NIPT) in a research note published on Tuesday morning, MarketBeat.
Panmure Gordon Keeps Premaitha Health Plc (LON:NIPT) As Buy; Has Target Of ...  OctaFinance.com
Premaitha Health Plc (LON:NIPT) Receives Buy Rating From Panmure Gordon Analysts  Risers & Fallers
Premaitha Health PLC Premaitha Health signs Investment Agreement with Thermo ...
This investment will enable Premaitha to offer enhanced commercial solutions to clinical laboratories across Europe and other international territories, enabling more pregnant women to access the benefits of NIPT.
Premaitha Health PLC (NIPT) Given "Buy" Rating at Panmure Gordon
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “buy” rating reiterated by analysts at Panmure Gordon in a research report issued to clients and investors on Wednesday, Marketbeat.
Premaitha Health Plc IONA� – Up, running and available on the NHS  DirectorsTalk Interviews
Recent Broker Updates On Premaitha Health (LON:NIPT)  Risers & Fallers
Premaitha Health PLC 30.6% Potential Upside Indicated by Panmure Gordon
Premaitha Health PLC using EPIC/TICKER code LON:NIPT has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Panmure Gordon.
Premaitha Health PLC's (VIY) Buy Rating Reaffirmed at Panmure Gordon
Premaitha Health PLC logo Panmure Gordon reiterated their buy rating on shares of Premaitha Health PLC (LON:VIY) in a research report sent to investors on Friday morning, StockTargetPrices.
Premaitha Health PLC's (NIPT) "Buy" Rating Reaffirmed at ...  Corvus Business Newswire
PEG Ratio (5 yr expected):
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
Premaitha Health partners with Visional Medical to provide the IONA test to ...
Manchester, UK and Chennai, India - 3 February 2016 - Premaitha Health plc (AIM: NIPT, "Premaitha" or "the Company") developer of the IONA� test, the first CE-marked non-invasive prenatal screening (NIPT) product, has signed an agreement with ...
Premaitha Health Signs Deal With Visional Medical For Indian Market  London South East (registration) (blog)
Premaitha Health PLC (NIPT) Rating Reiterated by Panmure Gordon
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “buy” rating reissued by research analysts at Panmure Gordon in a report released on Wednesday, Analyst Ratings Network.
Premaitha Health PLC (NIPT) Given Buy Rating at Panmure Gordon  Zolmax
Premaitha Health Plc retained as Buy By Panmure Gordon
In an analyst rating update on Friday shares of Premaitha Health Plc (LON:NIPT) had their rating retained by analysts at Panmure Gordon.
Panmure Gordon Reiterates Buy Rating for Premaitha Health PLC (NIPT)  Intercooler Financial
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company, But Struggles To Sell Energy Unit  London South East
Related articles »